R

Avidity Biosciences
D

RNA

49.730
USD
-1.06
(-2.09%)
مغلق
حجم التداول
69,373
الربح لكل سهم
-4
العائد الربحي
-
P/E
-14
حجم السوق
7,255,772,949
أصول ذات صلة الأخبار المقالات

العنوان: Avidity Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.